SERTRALINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sertraline, and when can generic versions of Sertraline launch?
Sertraline is a drug marketed by Almatica, Amneal, Appco, Novitium Pharma, Umedica, Zenara, Zydus Lifesciences, Aurobindo Pharma, Ranbaxy Labs Ltd, Strides Pharma, Accord Hlthcare, Ascent Pharms Inc, Chartwell Molecular, Granules, Heritage, Heritage Pharma Avet, Hikma Pharms, Invagen Pharms, Ivax Sub Teva Pharms, Lupin, Mylan Pharms Inc, Oxford Pharms, Pharmaco, Pharmobedient, Quagen, Reyoung, Sciegen Pharms, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Torrent Pharms, Tp Anda Holdings, and Zydus. and is included in thirty-seven NDAs.
The generic ingredient in SERTRALINE is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the sertraline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sertraline
A generic version of SERTRALINE was approved as sertraline hydrochloride by STRIDES PHARMA on June 30th, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SERTRALINE?
- What are the global sales for SERTRALINE?
- What is Average Wholesale Price for SERTRALINE?
Summary for SERTRALINE
| US Patents: | 0 |
| Applicants: | 32 |
| NDAs: | 37 |
| Drug Prices: | Drug price information for SERTRALINE |
| Drug Sales Revenues: | Drug sales revenues for SERTRALINE |
| DailyMed Link: | SERTRALINE at DailyMed |
US Patents and Regulatory Information for SERTRALINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quagen | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 078626-001 | Jan 31, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Heritage Pharma Avet | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 077663-001 | Feb 6, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Molecular | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 077162-003 | Feb 6, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
